Cognitive impairment across ALS clinical stages in a population-based cohort

Objective To assess the association of the degree of severity of motor impairment to that of cognitive impairment in a large cohort of patients with amyotrophic lateral sclerosis (ALS). Methods This is a population-based cross-sectional study on patients with ALS incident in Piemonte, Italy, between 2007 and 2015. Cognitive status was classified according to the revised ALS–FTD Consensus Criteria. The King system and the Milano Torino Staging system (MiToS) were used for defining the severity of motor impairment. Results Of the 797 patients included in the study, 163 (20.5%) had ALS–frontotemporal dementia (FTD), 38 (4.8%) cognitive and behavioral impairment (ALScbi), 132 (16.6%) cognitive impairment (ALSci), 63 (7.9%) behavioral impairment (ALSbi), 16 (2.0%) nonexecutive impairment, and 385 (48.2%) were cognitively normal. According to King staging, the frequency of cases with ALS-FTD progressively increased from 16.5% in stage 1–44.4% in stage 4; conversely, the frequency of ALSci, ALSbi, and ALScbi increased from King stage 1 to King stage 3 and decreased thereafter. A similar pattern was observed with the MiToS staging. ALS-FTD was more frequent in patients with bulbar involvement at time of cognitive testing. Patients with C9ORF72 expansion (n = 61) showed more severe cognitive impairment with increasing King and MiToS stages. Conclusion Our findings suggest that ALS motor and cognitive components may worsen in parallel, and that cognitive impairment becomes more pronounced when bulbar function is involved. Our data support the hypothesis that ALS pathology disseminates in a regional ordered sequence, through a cortico-efferent spreading model.

[1]  A. Chiò,et al.  Validation of the revised classification of cognitive and behavioural impairment in ALS , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  A. Al-Chalabi,et al.  ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS , 2018, Neurology.

[3]  F. Madotto,et al.  Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS) , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[4]  Jennifer Murphy,et al.  What’s happening in Neurology® Clinical Practice , 2017, Neurology.

[5]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis , 2017, The Lancet.

[6]  Adriano Chiò,et al.  Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d’Aosta Register , 2017, JAMA neurology.

[7]  G. Riva,et al.  Brain-Computer Interface for Clinical Purposes: Cognitive Assessment and Rehabilitation , 2017, BioMed research international.

[8]  G. Riva,et al.  An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS , 2017, Journal of Neurology.

[9]  M. Grossman,et al.  Author response: Cognitive reserve in frontotemporal degeneration: Neuroanatomic and neuropsychological evidence , 2017, Neurology.

[10]  Tibor,et al.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[11]  D. Lulé,et al.  Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis , 2016, Scientific Reports.

[12]  J. Trojanowski,et al.  Cognitive reserve in frontotemporal degeneration , 2016, Neurology.

[13]  F. Esposito,et al.  Neuropsychological assessment in different King's clinical stages of amyotrophic lateral sclerosis , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[14]  S. Teipel,et al.  No Change in Executive Performance in ALS Patients: A Longitudinal Neuropsychological Study , 2015, Neurodegenerative Diseases.

[15]  M. Pessiglione,et al.  Behavioral variant frontotemporal dementia patients do not succumb to the Allais paradox , 2014, Front. Neurosci..

[16]  C. Volpato,et al.  Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  M. Schoenfeld,et al.  Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment , 2014, BMC Neuroscience.

[18]  A. Al-Chalabi,et al.  Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[19]  Adriano Chiò,et al.  Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  C. Ki,et al.  Spectrum of Cognitive Impairment in Korean ALS Patients without Known Genetic Mutations , 2014, PloS one.

[21]  John L. Robinson,et al.  Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD) , 2014, Acta Neuropathologica.

[22]  A. Chiò,et al.  Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  Murray Grossman,et al.  Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis , 2013, Annals of neurology.

[24]  O. Hardiman,et al.  Cognitive changes predict functional decline in ALS , 2013, Neurology.

[25]  J. Hodges,et al.  Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients’ behavioral changes than physical disability: a comparative study , 2012, BMC Neurology.

[26]  Y. Stern Cognitive reserve in ageing and Alzheimer's disease , 2012, The Lancet Neurology.

[27]  Jonathan M. Bekisz,et al.  Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  A. Chiò,et al.  Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV , 2012, Neurology.

[29]  A. Al-Chalabi,et al.  A proposed staging system for amyotrophic lateral sclerosis , 2012, Brain : a journal of neurology.

[30]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[31]  A. Tennant,et al.  Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease , 2011, Health and quality of life outcomes.

[32]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[33]  O. Hardiman,et al.  The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  F. Manes,et al.  Decision-Making in Frontotemporal Dementia: Clinical, Theoretical and Legal Implications , 2011, Dementia and Geriatric Cognitive Disorders.

[35]  J. Garre-Olmo,et al.  Incidence and subtypes of early-onset dementia in a geographically defined general population , 2010, Neurology.

[36]  A. Chiò,et al.  Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of life , 2010, European journal of neurology.

[37]  M. Freedman,et al.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[38]  R. Petersen,et al.  Alzheimer's disease and mild cognitive impairment. , 2007, Neurologic clinics.

[39]  A. Ludolph,et al.  Cognitive function in bulbar– and spinal–onset amyotrophic lateral sclerosis , 2005, Journal of Neurology.

[40]  O. Blin,et al.  A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[41]  R. Petersen,et al.  The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994 , 2004, Neurology.

[42]  Catherine Lomen-Hoerth,et al.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.

[43]  P. Leigh,et al.  Correlates of Quality of Life in people with motor neuron disease (MND) , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[44]  P N Leigh,et al.  Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[45]  J. Hodges,et al.  Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia. , 2017, Journal of Alzheimer's disease : JAD.

[46]  Martijn P. van den Heuvel,et al.  Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis , 2016, NeuroImage.

[47]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.